End-Stage Renal Disease
Conditions
Interventions
Normal group:none
Sponsors
Huadu District Peoples Hospital of Guangzhou
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Dialysis duration >= 3 months, with each session lasting 4 hours and occurring 3 times per week, or a total weekly dialysis duration of 12 hours; 2.Complete medical records (including name, age, identification details, comorbidities, primary cause of renal failure, surgical history, current medications, and current dialysis regimen); 3.Participants must sign an informed consent form and voluntarily agree to participate in this study.
Exclusion criteria
Exclusion criteria: 1.Patients with a history of diagnosed thyroid disorders, including hyperthyroidism, hypothyroidism, thyroid nodules, etc. 2.Patients with a history of cardiac disease, including coronary heart disease, arrhythmia, heart failure, myocardial infarction, congenital heart disease, etc. 3.Patients with concurrent malignant tumors; 4.Patients with recent severe infectious diseases; 5.Individuals who have taken medications affecting thyroid function within the past month, including iodine-containing drugs, glucocorticoids, beta-blockers, etc. 6.Expected survival period < 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thyroid Stimulating Hormone;Free Triiodothyronine;Free Thyroxine; | — |
Countries
China
Contacts
Public ContactLei Zihan
Huadu District Peoples Hospital of Guangzhou
Outcome results
None listed